Editas Medicine (EDIT) Share-based Compensation (2015 - 2025)
Editas Medicine (EDIT) recorded Share-based Compensation of $2.23 million in Q3 2025, down 53.6% from $4.8 million a year earlier and down 16.4% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Share-based Compensation (2015 - 2025) Analysis & Trends
On a TTM basis, Editas Medicine's Share-based Compensation came in at $11.89 million as of Sep 30, 2025, down 47.7% year-over-year; for FY2024, it came in at $21.42 million, up 8.2% from FY2023.
- Annual Share-based Compensation has a five-year compound annual growth rate of -4.7% (FY2019 to FY2024).
- Across earlier years, Share-based Compensation came in at $19.8 million in FY2023 (-32.4%), $29.29 million in FY2022 (-32.5%), $43.4 million in FY2021 (+87.4%) and $23.16 million in FY2020 (-15.0%).
- The Q3 2025 figure is the lowest quarterly Share-based Compensation since Q4 2015.
- On a year-over-year basis, Share-based Compensation has declined for four consecutive quarters, with an average decline of 15.1% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 149.7% in Q2 2021, against a decline of 60.7% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.66 million (Q2 2025), $2.98 million (Q1 2025) and $4.02 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Editas Medicine | 234.09 Mn | -477.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 5.01 Mn |
| Mar 31, 2024 | 7.59 Mn |
| Dec 31, 2023 | 5.35 Mn |
| Sep 30, 2023 | 4.73 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Mar 31, 2023 | 4.51 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 5.88 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | 11.43 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 10.01 Mn |
| Jun 30, 2021 | 13.53 Mn |
| Mar 31, 2021 | 12.20 Mn |
| Dec 31, 2020 | 5.67 Mn |
API Access
Editas Medicine Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();